| Literature DB >> 28958602 |
Sara Lustigman1, Benjamin L Makepeace2, Thomas R Klei3, Simon A Babayan4, Peter Hotez5, David Abraham6, Maria Elena Bottazzi5.
Abstract
Human onchocerciasis - commonly known as river blindness - is one of the most devastating yet neglected tropical diseases, leaving many millions in sub-Saharan Africa blind and/or with chronic disabilities. Attempts to eliminate onchocerciasis, primarily through the mass drug administration of ivermectin, remains challenging and has been heightened by the recent news that drug-resistant parasites are developing in some populations after years of drug treatment. Needed, and needed now, in the fight to eliminate onchocerciasis are new tools, such as preventive and therapeutic vaccines. This review summarizes the progress made to advance the onchocerciasis vaccine from the research laboratory into the clinic.Entities:
Keywords: Onchocerca volvulus; elimination; vaccine; vaccine candidates
Mesh:
Substances:
Year: 2017 PMID: 28958602 PMCID: PMC5748257 DOI: 10.1016/j.pt.2017.08.011
Source DB: PubMed Journal: Trends Parasitol ISSN: 1471-4922